CN102440957B - Terlipressin acetate nasal cavity spray and preparation method thereof - Google Patents
Terlipressin acetate nasal cavity spray and preparation method thereof Download PDFInfo
- Publication number
- CN102440957B CN102440957B CN2011104276360A CN201110427636A CN102440957B CN 102440957 B CN102440957 B CN 102440957B CN 2011104276360 A CN2011104276360 A CN 2011104276360A CN 201110427636 A CN201110427636 A CN 201110427636A CN 102440957 B CN102440957 B CN 102440957B
- Authority
- CN
- China
- Prior art keywords
- acetic acid
- terlipressin
- spray
- nasal mist
- chlorobutanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104276360A CN102440957B (en) | 2011-12-16 | 2011-12-16 | Terlipressin acetate nasal cavity spray and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104276360A CN102440957B (en) | 2011-12-16 | 2011-12-16 | Terlipressin acetate nasal cavity spray and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102440957A CN102440957A (en) | 2012-05-09 |
CN102440957B true CN102440957B (en) | 2013-09-25 |
Family
ID=46004219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011104276360A Active CN102440957B (en) | 2011-12-16 | 2011-12-16 | Terlipressin acetate nasal cavity spray and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102440957B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112969449A (en) * | 2018-06-15 | 2021-06-15 | 费灵有限公司 | Terlipressin composition and application thereof |
US20220080023A1 (en) * | 2018-12-21 | 2022-03-17 | Arecor Limited | Novel composition |
JP2022533759A (en) * | 2019-05-22 | 2022-07-25 | バイオヴァイ インコーポレイテッド | Formulations of terlipressin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1126439A (en) * | 1993-06-29 | 1996-07-10 | 凡林有限公司 | Compositions for nasal administration of desmopressin |
CN1126440A (en) * | 1993-06-29 | 1996-07-10 | 凡林有限公司 | Stabilized pharmaceutical peptide compositions |
-
2011
- 2011-12-16 CN CN2011104276360A patent/CN102440957B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1126439A (en) * | 1993-06-29 | 1996-07-10 | 凡林有限公司 | Compositions for nasal administration of desmopressin |
CN1126440A (en) * | 1993-06-29 | 1996-07-10 | 凡林有限公司 | Stabilized pharmaceutical peptide compositions |
Also Published As
Publication number | Publication date |
---|---|
CN102440957A (en) | 2012-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2574167T3 (en) | LIQUID NOSE SPRAY CONTAINING low-dose naltrexone | |
CA3037089C (en) | Sublingual pharmaceutical composition of edaravone and (+)-2-borneol | |
CN102949709B (en) | External gel used for treating diabetic foot, and preparation method and application thereof | |
JP2003506416A (en) | Moxifloxacin / sodium chloride preparation | |
JP5993442B2 (en) | Pharmaceutical composition | |
CN101214235A (en) | Ibuprofen amino acid salt injection and preparation thereof | |
CN102440957B (en) | Terlipressin acetate nasal cavity spray and preparation method thereof | |
MX2012008516A (en) | Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect. | |
MXPA06009094A (en) | Controlled release formulations. | |
JP6595717B2 (en) | Composition comprising hydrophilized sulfasalazine and hyaluronic acid for the treatment of osteoarthritis and method for producing the same | |
TW201729830A (en) | Pharmaceutical composition intended to be administred to nasal mucosa | |
CN101978945B (en) | A kind of ibuprofen medicinal composition | |
TW201440783A (en) | Pharmaceutical composition comprising micafungin or the salts thereof | |
CN102885766B (en) | Dexketoprofen injection and preparation method thereof | |
CN102008461B (en) | A kind of ibuprofen drug composite for injection | |
CN105769756B (en) | A kind of fumaric acid Sitafloxacin hydrate injection and preparation method thereof | |
CN102240261A (en) | Preparation method and medicinal purpose of glucomannan injection | |
CN102716107B (en) | water-soluble ibuprofen pharmaceutical composition | |
CN103989685A (en) | Preparation method of compound lamotrigine subcutaneous implantable controlled-release glue rod | |
CN108992394A (en) | A kind of preparation method of pseudoephedrine hydrochloride slow release preparation | |
CN102895232B (en) | Cefonicid compound-containing medicinal composition and its preparation method | |
CN101919799B (en) | Novel sustained-release transdermal medicament delivery system | |
CN109172600B (en) | A kind of medical composition and its use | |
WO2017088177A1 (en) | Mussel adhesive protein product, and use thereof in preventing and suppressing neuronal inflammation | |
CN102973588A (en) | Application of carrageenan in preparing medicament for treating diabetes mellitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 518057 Nanshan District, Guangdong Province, a high tech in the middle of the road No. ten Shenzhen biological incubation base, building 412, room 2, No. Applicant after: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. Address before: 518000, overseas student Pioneer Building, 29 South Ring Road, Nanshan hi tech Zone, Guangdong, Shenzhen 1702 Applicant before: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120509 Assignee: Nanjing Xingyin Pharmaceutical Group Co.,Ltd. Assignor: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. Contract record no.: 2015440020183 Denomination of invention: Terlipressin acetate nasal cavity spray and preparation method thereof Granted publication date: 20130925 License type: Exclusive License Record date: 20150519 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161209 Address after: Zi street Jinhui road Shenzhen 518118 Guangdong province Pingshan pit No. 14 Shenzhen Biomedical Innovation Industrial Park Building No. 7 Patentee after: Shenzhen Jianxiang Biological Pharmaceutical Co Ltd Address before: 518057 Nanshan District, Guangdong Province, a high tech in the middle of the road No. ten Shenzhen biological incubation base, building 412, room 2, No. Patentee before: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. |